PrEP, or pre-exposure prophylaxis, is a once-daily pill that can reduce your chance of getting HIV by more than 90%. According to the Centers for Disease Control and Prevention (CDC),…

A promising HIV vaccine candidate demonstrated its power by neutralizing HIV strains in mice, guinea pigs and monkeys, and is almost ready for human testing. The findings were published on June 4th…

An HIV-negative child received a liver transplant from its HIV-positive mother and now appears to have no evidence of HIV infection apart from a very weak antibody response. The case…

New results are raising hopes for easing one challenge of living with HIV: the need to take daily pills for life, both to ward off HIV/AIDS and to lower the…

The Food and Drug Administration has approved the drug PrEP, also known as Truvada, for adolescents. In an anniuncement released this week, the government health agency recommended that the daily treatment be…

National Native HIV/AIDS Awareness Day (#NNHAAD)  is observed on the first day of Spring each year. The Spring Equinox is a time of equality and balance. It is a time of…

The number of people taking PrEP in the United States is steadily increasing, exceeding 77,000 in 2016, according to figures released yesterday by AIDSVu in conjunction with the 25th Conference on…

Despite advances in the treatment and prevention of HIV, many barriers still block African Americans and people of color from getting the health care they need. When it comes to HIV, that's…

Florida health officials say the department plans to offer HIV prevention drug PrEP for free throughout the state by the end of 2018. Florida's rate of new HIV diagnoses is more…

Gilead Sciences, Inc.,  a research-based biopharmaceutical company announced the launch of the Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative today. The initiative is a 10-year, $100 million commitment to…